Lawmakers and regulators at federal and state levels concerned about increasing healthcare prices should understand who is involved in the process, especially as they attempt to address rising pharmaceutical costs.
Key points:
- Drug spending in the United States has been increasing in recent years and is expected to continue to grow due to rising drug prices and increased drug utilization.
- It is important for policymakers to understand the role of everyone involved in the supply chain in order to craft effective legislation to help control rising drug costs.